Skip to content

Establishment of a cohort for immunophenotyping of inflammatory arthropathy

Establishment of a cohort for immunophenotyping of inflammatory arthropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044676
Enrollment
Unknown
Registered
2021-03-25
Start date
2021-03-20
Completion date
Unknown
Last updated
2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory arthropathy

Interventions

patients with inflammatory arthropathy and matched healthy people and patients with unrelated diseases:Nil

Sponsors

The First Affiliated Hospital of Suzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) The age at the time of signing the informed consent form is between 18 and 70 years old (including both ends), regardless of gender. 2) Patients with definite diagnosis according to the classification criteria of inflammatory arthropathy of American Rheumatic Association ((ACR)) and European Rheumatic Union ((EULAR)).

Exclusion criteria

Exclusion criteria: 1) Have a history of lymphoproliferative disease, or may be various signs or symptoms of lymphoproliferative disease. 2) have a history of malignant tumor. 3) have mental or neurological diseases, unwilling to communicate or have language barriers, unable to fully understand and collaborate. 4) the researchers believe that there are any other factors that may affect the conduct of this study or the evaluation of the results.

Design outcomes

Primary

MeasureTime frame
Joint symptoms;Quality of life assessment scale;Emotional evaluation scale;Blood routine;Blood biochemistry;autoantibody;Joint imaging examination;

Countries

China

Contacts

Public ContactWu Jian

The First Affiliated Hospital of Suzhou University

xinchang@suda.edu.cn+86 512-67780059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026